+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nutrigenomics Market - Global Forecast 2026-2032- Product Image
Nutrigenomics Market - Global Forecast 2026-2032- Product Image
Sale

Nutrigenomics Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968570
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nutrigenomics Market is projected to reach USD 785.88 Million in 2026. It is expected to continue growing at a CAGR of 17.83%, reaching USD 2.11 Billion by 2032.

Nutrigenomics is moving from a niche wellness concept to a data-driven segment of precision nutrition, connecting genetic variation with dietary response, metabolic risk, and personalized health guidance. The field is supported by decades of genomic research, the steep decline in DNA sequencing costs reported by the National Human Genome Research Institute, and the growing burden of diet-related noncommunicable diseases, which the World Health Organization identifies as responsible for most global mortality.

Market demand is being shaped by consumers seeking personalized nutrition plans, healthcare systems emphasizing prevention, and food, supplement, diagnostics, and digital health stakeholders integrating genetic insights into product development. Scientifically credible nutrigenomics depends on validated gene-diet associations, responsible interpretation, transparent consent, and clear separation between evidence-based recommendations and lifestyle marketing claims.

Transformative Shifts in Nutrigenomics

The nutrigenomics landscape is being transformed by the convergence of affordable genotyping, multi-omics analytics, wearable health data, and rising consumer interest in preventive care. Providers are shifting from single-gene diet claims toward broader models that combine genetics with biomarkers, microbiome profiles, lifestyle behavior, dietary intake, and clinical history.

Regulation and trust are becoming decisive differentiators. Data privacy rules such as the European Union’s General Data Protection Regulation, genetic nondiscrimination protections in the United States, and tighter scrutiny of direct-to-consumer health testing are pushing providers to strengthen consent, clinical validation, cybersecurity, and claims substantiation. This is accelerating collaboration among laboratories, nutrition brands, healthcare providers, insurers, and digital therapeutics platforms.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the analytical capacity of nutrigenomics by identifying patterns across genomic variants, dietary intake, blood biomarkers, microbiome data, continuous glucose monitoring, and lifestyle records. AI-enabled models can improve personalization at scale, support nutrition coaching, and help researchers prioritize gene-nutrient interactions for further validation.

The cumulative impact is not purely technical; it is also operational and ethical. AI can reduce manual interpretation time and support adaptive recommendations, but biased training data, limited representation in genomic datasets, and insufficient clinical validation can weaken recommendations. Industry leaders must therefore use explainable models, diverse datasets, human expert oversight, secure data governance, and continuous post-market evidence generation to maintain scientific credibility.

Regional Dynamics Shaping Adoption

North America leads nutrigenomics adoption through advanced genetic testing infrastructure, high digital health engagement, established preventive wellness demand, and consumer familiarity with DNA-based health insights. Europe is shaped by rigorous privacy governance, public health nutrition policies, clinical research networks, and strong expectations for evidence-based claims. Asia-Pacific is expanding as China, Japan, India, South Korea, and Australia combine growing middle-class wellness spending with genomics capacity, aging-population priorities, and diet-related chronic disease prevention.

Latin America shows rising opportunity as Brazil and Mexico address obesity, diabetes, and cardiovascular risk, creating demand for personalized dietary interventions that remain affordable and culturally relevant. The Middle East, particularly GCC markets, is investing in genomics, diabetes prevention, national health transformation, and premium wellness services. Africa is earlier in commercialization, but long-term potential is significant as genomic diversity, mobile health adoption, public nutrition initiatives, and precision public health research gradually converge.

Strategic Group Insights

ASEAN markets are gaining relevance as urbanization, mobile-first healthcare access, and rising nutrition awareness create demand for affordable DNA-based wellness and preventive health services. GCC countries are building precision health capacity through national genomics initiatives, high healthcare spending, and prevention programs targeting obesity, diabetes, and cardiometabolic disease.

The European Union remains a benchmark for responsible nutrigenomics because of the General Data Protection Regulation, clinical research standards, and strong consumer protection requirements. BRICS countries are important for scale, genomic diversity, and localized nutrition needs, though affordability, infrastructure maturity, and regulatory consistency vary across members. G7 economies support premium innovation through mature diagnostics, biotechnology investment, academic research, and digital health ecosystems, while NATO countries overlap with many high-income markets where cybersecurity, data sovereignty, and health resilience influence nutrigenomics adoption.

Country-Level Market Signals

The United States is a major nutrigenomics market due to direct-to-consumer testing familiarity, digital health adoption, preventive wellness demand, and strong supplement and functional food sectors. Canada benefits from public health credibility, research capacity, and privacy-conscious adoption, while Mexico and Brazil present growth potential tied to obesity, diabetes, cardiovascular prevention, and increasing interest in culturally adapted nutrition guidance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine nutrition research, diagnostics capacity, regulated consumer health markets, and growing demand for personalized wellness, while Russia’s opportunity is influenced by scientific capability, data localization considerations, and market access constraints. China and India offer scale, diverse dietary patterns, and rapidly expanding health technology ecosystems; Japan and South Korea bring advanced aging, wellness, and genomics markets; and Australia supports adoption through preventive health awareness, established biotechnology infrastructure, and strong consumer interest in evidence-led nutrition.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically defensible nutrigenomics by investing in validated gene-diet evidence, transparent reporting, and clear limitations for consumers and clinicians. Product claims must align with regulatory expectations and avoid overstating causality where evidence is associative, population-specific, or dependent on lifestyle and environmental context.

Companies should also build interoperable platforms that combine genetics with biomarkers, lifestyle data, microbiome insights, and culturally specific dietary guidance. Strategic partnerships with accredited laboratories, registered dietitians, healthcare providers, and academic researchers can improve trust and implementation. Privacy-by-design architecture, explainable AI, inclusive genomic datasets, consent management, and post-market outcome tracking should be treated as core market-entry requirements rather than optional differentiators.

Research Methodology

This executive summary is developed using secondary research from recognized public health agencies, regulatory frameworks, peer-reviewed scientific literature, genomics cost-trend data, and industry observations across precision nutrition, diagnostics, digital health, and functional food markets. The analysis emphasizes verified trends and evidence-backed market signals rather than unsupported market sizing assumptions.

Research inputs are triangulated across disease-burden data, regulatory developments, technology adoption signals, regional healthcare infrastructure, genomics readiness, and consumer wellness behavior. The methodology evaluates market attractiveness through evidence quality, commercialization readiness, data privacy maturity, affordability, clinical integration, cultural relevance, and capacity for responsible AI-enabled personalization.

Conclusion and Strategic Outlook

Nutrigenomics is positioned to become a key enabler of precision nutrition as consumers, clinicians, and health systems seek more personalized prevention strategies for diet-related chronic disease. The strongest opportunities will emerge where scientific validation, ethical data use, inclusive research, and practical dietary implementation are aligned.

The next phase of market growth will favor organizations that can translate complex genomic, biomarker, lifestyle, and nutritional data into clear, culturally relevant, and clinically responsible guidance. Trust, inclusivity, regulatory compliance, cybersecurity, and measurable health outcomes will define competitive advantage in the global nutrigenomics market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nutrigenomics Market, by Offering
7.1. Introduction
7.2. Reagents & Kits
7.3. Services
7.3.1. Genetic Counseling Services
7.3.2. Research & Development Services
8. Nutrigenomics Market, by Technique
8.1. Introduction
8.2. Blood
8.3. Buccal Swab
8.4. Saliva
9. Nutrigenomics Market, by Technology
9.1. Introduction
9.2. Bioinformatics & Data Analytics
9.3. Genotyping
9.4. Microarray Technology
9.5. Next Generation Sequencing (NGS)
9.6. Polymerase Chain Reaction (PCR)
10. Nutrigenomics Market, by Application
10.1. Introduction
10.2. Cancer Prevention & Management
10.3. Disease Management
10.3.1. Cardiovascular
10.3.1.1. Cholesterol
10.3.1.2. Hypertension
10.3.2. Diabetes
10.3.2.1. Type 1
10.3.2.2. Type 2
10.3.3. Obesity
10.4. Personalized Nutrition
10.5. Sports Nutrition
10.5.1. Endurance
10.5.2. Post Workout
10.5.3. Pre Workout
10.6. Weight Management
11. Nutrigenomics Market, by End-User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Fitness & Wellness Centers
11.4. Hospitals & Clinics
11.5. Research & Academic Institutes
12. Nutrigenomics Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Nutrigenomics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Nutrigenomics Market, by Country
14.1. United States
14.2. Germany
14.3. China
14.4. India
14.5. United Kingdom
14.6. Japan
14.7. Canada
14.8. Russia
14.9. Brazil
14.10. Italy
14.11. Mexico
14.12. France
14.13. Spain
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Atlas Laboratories Ltd.
16.2. DNAlife
16.3. EliteVita
16.4. Genomics Research and Solutions Pvt Ltd.
16.5. Genosalut Balear SL
16.6. Genova Diagnostics Inc.
16.7. GX Sciences, LLC
16.8. HOLISTIC HEALTH INTERNATIONAL, LLC
16.9. LifecodeGx Ltd
16.10. Mapmygenome
16.11. myDNA Life Australia Pty Ltd.
16.12. NuGenomics
16.13. Nutrigenomix Inc.
16.14. Randox Health LTD
16.15. The Gene Box
16.16. Wellness Psychiatry, PLLC
16.17. Xcode Life
List of Figures
FIGURE 1. GLOBAL NUTRIGENOMICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NUTRIGENOMICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NUTRIGENOMICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NUTRIGENOMICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NUTRIGENOMICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NUTRIGENOMICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL NUTRIGENOMICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NUTRIGENOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL GENETIC COUNSELING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL GENETIC COUNSELING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL GENETIC COUNSELING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL RESEARCH & DEVELOPMENT SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL RESEARCH & DEVELOPMENT SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL RESEARCH & DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL BUCCAL SWAB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL BUCCAL SWAB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL BUCCAL SWAB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL BIOINFORMATICS & DATA ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL BIOINFORMATICS & DATA ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BIOINFORMATICS & DATA ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL GENOTYPING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL MICROARRAY TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MICROARRAY TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MICROARRAY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CANCER PREVENTION & MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CANCER PREVENTION & MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CANCER PREVENTION & MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CHOLESTEROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CHOLESTEROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CHOLESTEROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HYPERTENSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HYPERTENSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HYPERTENSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL TYPE 1 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TYPE 1 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TYPE 1 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TYPE 2 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TYPE 2 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TYPE 2 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL OBESITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL OBESITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL OBESITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PERSONALIZED NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PERSONALIZED NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PERSONALIZED NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SPORTS NUTRITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SPORTS NUTRITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SPORTS NUTRITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ENDURANCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ENDURANCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ENDURANCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL POST WORKOUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL POST WORKOUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL POST WORKOUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PRE WORKOUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PRE WORKOUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PRE WORKOUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL WEIGHT MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL WEIGHT MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL WEIGHT MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL NUTRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 135. EUROPE NUTRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. EUROPE NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 137. EUROPE NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 138. EUROPE NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 139. EUROPE NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 140. EUROPE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. EUROPE NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 142. EUROPE NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 143. EUROPE NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 144. EUROPE NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 145. EUROPE NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 157. AFRICA NUTRIGENOMICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. AFRICA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 159. AFRICA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 160. AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 161. AFRICA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 162. AFRICA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. AFRICA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 164. AFRICA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 165. AFRICA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 166. AFRICA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 167. AFRICA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL NUTRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. ASEAN NUTRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. ASEAN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 171. ASEAN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 172. ASEAN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 173. ASEAN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 174. ASEAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. ASEAN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 176. ASEAN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 177. ASEAN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 178. ASEAN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 179. ASEAN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 180. GCC NUTRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 181. GCC NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 182. GCC NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 183. GCC NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 184. GCC NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. GCC NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. GCC NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 187. GCC NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 188. GCC NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 189. GCC NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 190. GCC NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 202. BRICS NUTRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 203. BRICS NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 204. BRICS NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 205. BRICS NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 206. BRICS NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 207. BRICS NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. BRICS NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 209. BRICS NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 210. BRICS NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 211. BRICS NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 212. BRICS NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 213. G7 NUTRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. G7 NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 215. G7 NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 216. G7 NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 217. G7 NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. G7 NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. G7 NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 220. G7 NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 221. G7 NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 222. G7 NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 223. G7 NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 224. NATO NUTRIGENOMICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 225. NATO NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 226. NATO NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 227. NATO NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 228. NATO NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 229. NATO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. NATO NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 231. NATO NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 232. NATO NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 233. NATO NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 234. NATO NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 235. GLOBAL NUTRIGENOMICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 236. UNITED STATES NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 238. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 239. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 240. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 241. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 242. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 247. GERMANY NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. GERMANY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 249. GERMANY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 250. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 251. GERMANY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. GERMANY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. GERMANY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 254. GERMANY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 255. GERMANY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 256. GERMANY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 257. GERMANY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 258. CHINA NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 259. CHINA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 260. CHINA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 261. CHINA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 262. CHINA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 263. CHINA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. CHINA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 265. CHINA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 266. CHINA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 267. CHINA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 268. CHINA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 269. INDIA NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 270. INDIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 271. INDIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 272. INDIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 273. INDIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 274. INDIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 275. INDIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 276. INDIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 277. INDIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 278. INDIA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 279. INDIA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 282. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 284. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 291. JAPAN NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 292. JAPAN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 293. JAPAN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 294. JAPAN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 295. JAPAN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 296. JAPAN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 297. JAPAN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 298. JAPAN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 299. JAPAN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 300. JAPAN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 301. JAPAN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 302. CANADA NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. CANADA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 304. CANADA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 305. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 306. CANADA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 307. CANADA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 308. CANADA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 309. CANADA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 310. CANADA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 311. CANADA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 312. CANADA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 313. RUSSIA NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 314. RUSSIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 315. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 316. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 317. RUSSIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 318. RUSSIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 319. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 320. RUSSIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 321. RUSSIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 322. RUSSIA NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 323. RUSSIA NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 324. BRAZIL NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. BRAZIL NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 333. BRAZIL NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 334. BRAZIL NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 335. ITALY NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. ITALY NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 337. ITALY NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 338. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 339. ITALY NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 340. ITALY NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 341. ITALY NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 342. ITALY NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 343. ITALY NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 344. ITALY NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 345. ITALY NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 346. MEXICO NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 347. MEXICO NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 348. MEXICO NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 349. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 350. MEXICO NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 351. MEXICO NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. MEXICO NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 353. MEXICO NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 354. MEXICO NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 355. MEXICO NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 356. MEXICO NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 357. FRANCE NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 358. FRANCE NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 359. FRANCE NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 360. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 361. FRANCE NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 362. FRANCE NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 363. FRANCE NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 364. FRANCE NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 365. FRANCE NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 366. FRANCE NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 367. FRANCE NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 368. SPAIN NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 369. SPAIN NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 370. SPAIN NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 371. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 372. SPAIN NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 373. SPAIN NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 374. SPAIN NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 375. SPAIN NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 376. SPAIN NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 377. SPAIN NUTRIGENOMICS MARKET SIZE, BY SPORTS NUTRITION, 2017-2032 (USD MILLION)
TABLE 378. SPAIN NUTRIGENOMICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 379. AUSTRALIA NUTRIGENOMICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 380. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 381. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 382. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 383. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 384. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 385. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY DISEASE MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 386. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 387. AUSTRALIA NUTRIGENOMICS MARKET SIZE, BY DIABETES, 2017-2032 (USD MILLION)
TABLE 388. AUSTRALIA NUTRIGENOMICS MARKET

Companies Mentioned

  • Atlas Laboratories Ltd.
  • DNAlife
  • EliteVita
  • Genomics Research and Solutions Pvt Ltd.
  • Genosalut Balear SL
  • Genova Diagnostics Inc.
  • GX Sciences, LLC
  • HOLISTIC HEALTH INTERNATIONAL, LLC
  • LifecodeGx Ltd
  • Mapmygenome
  • myDNA Life Australia Pty Ltd.
  • NuGenomics
  • Nutrigenomix Inc.
  • Randox Health LTD
  • The Gene Box
  • Wellness Psychiatry, PLLC
  • Xcode Life

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 785.88 Million
Forecasted Market Value ( USD ) by 2032 $ 2110 Million
Compound Annual Growth Rate17.8%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Nutrigenomics - Global Strategic Business Report - Product Image

Nutrigenomics - Global Strategic Business Report

  • Report
  • 168 Pages
  • Global
From
Nutrigenomics Market Report by Product, Sample Type, Application, End User, and Region 2026-2034 - Product Image

Nutrigenomics Market Report by Product, Sample Type, Application, End User, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Nutrigenomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Nutrigenomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 183 Pages
  • Global
From
Nutrigenomics Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Nutrigenomics Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Nutrigenomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Nutrigenomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From

About the Nutrigenomics Market

Nutrigenomics is a field of study that focuses on the relationship between nutrition and genetics. It is a sub-discipline of genomics, which is the study of the structure, function, and evolution of genomes. Nutrigenomics seeks to understand how nutrition affects gene expression and how genetic variation affects the response to dietary components. It is a rapidly growing field, with research focusing on the development of personalized nutrition plans based on an individual's genetic makeup. Nutrigenomics has the potential to revolutionize the way we approach nutrition and health. By understanding how genetic variation affects the response to dietary components, it can help to identify the most effective dietary interventions for individuals. This could lead to improved health outcomes and a reduction in the risk of chronic diseases. Some companies in the nutrigenomics market include 23andMe, Nutrigenomix, GenoPalate, and DNAFit. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.